CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 254 enrolled
Drug / intervention
Rapeseed oil +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03025620
NCT03025620N/ACompleted
CompareCT.gov

Investigation of the Relationship Between Alpha-linolenic Acid and Arterial, Biochemical, Biological Parameters in Older Persons With History of Cardiovascular Events and/or Moderate Cognitive Impairment

Assistance Publique - Hôpitaux de Paris·interventional·Posted Jan 19, 2017·Updated Jan 19, 2017

In Brief

A clinical study evaluating Rapeseed oil and Sunflower oil for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 254 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the antiatherogenic and anti-inflammatory potential of an adequate intake of alpha-linolenic acid in elderly.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Inflammation, Metabolism Disorder, Lipid
CountriesFrance
CollaboratorsInstitut Elevage, ITERG, SAINT HUBERT, TERRES UNIVIA, TERRES INOVIA

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 19, 2017
Enrollment StartNov 1, 2006
Primary CompletionFeb 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 9.5 years ago

Interventions

Rapeseed oildietary

Active comparator arm : Dietary Supplement: rapeseed oil supplementation (10g per day) and margarine with a high level of alpha-linolenic acid (12.5g per day) during 42 days.

Sunflower oildietary

Placebo comparator arm : Dietary Supplement: sunflower oil supplementation (10g per day) and margarine with a high level of inoleic acid (12.5g per day) during 42 days.